Comprehensive Dissection of PDGF-PDGFR Signaling Pathways in PDGFR Genetically Defined Cells

被引:98
作者
Wu, Erxi [1 ,2 ]
Palmer, Nathan [3 ]
Tian, Ze [1 ]
Moseman, Annie P. [1 ]
Galdzicki, Michal [1 ]
Wang, Xuetao [1 ]
Berger, Bonnie [3 ,4 ]
Zhang, Hongbing [5 ,6 ]
Kohane, Isaac S. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Childrens Hosp Boston, Informat Program, Boston, MA 02115 USA
[2] Harvard Univ, Div Hlth Sci & Technol, MIT, Cambridge, MA 02138 USA
[3] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA
[4] MIT, Dept Math, Cambridge, MA 02139 USA
[5] Tsinghua Univ, Peking Union Med Coll, Beijing, Peoples R China
[6] Chinese Acad Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Dept Physiol & Pathophysiol, Beijing 100864, Peoples R China
来源
PLOS ONE | 2008年 / 3卷 / 11期
基金
美国国家卫生研究院;
关键词
D O I
10.1371/journal.pone.0003794
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Despite the growing understanding of PDGF signaling, studies of PDGF function have encountered two major obstacles: the functional redundancy of PDGFR alpha and PDGFR beta in vitro and their distinct roles in vivo. Here we used wild-type mouse embryonic fibroblasts (MEF), MEF null for either PDGFR alpha, beta, or both to dissect PDGF-PDGFR signaling pathways. These four PDGFR genetically defined cells provided us a platform to study the relative contributions of the pathways triggered by the two PDGF receptors. They were treated with PDGF-BB and analyzed for differential gene expression, in vitro proliferation and differential response to pharmacological effects. No genes were differentially expressed in the double null cells, suggesting minimal receptor-independent signaling. Protean differentiation and proliferation pathways are commonly regulated by PDGFR alpha, PDGFR beta and PDGFR alpha/beta while each receptor is also responsible for regulating unique signaling pathways. Furthermore, some signaling is solely modulated through heterodimeric PDGFR alpha/beta.
引用
收藏
页数:15
相关论文
共 39 条
  • [21] PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases
    Levitzki, A
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (04) : 229 - 235
  • [22] Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells
    Li, Li
    Blumenthal, Donald K.
    Masaki, Takahisa
    Terry, Christi M.
    Cheung, Alfred K.
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 99 (06) : 1553 - 1563
  • [23] PDGF-C is a new protease-activated ligand for the PDGF α-receptor
    Li, XR
    Pontén, A
    Aase, K
    Karlsson, L
    Abramsson, A
    Uutela, M
    Bäckström, G
    Hellström, M
    Boström, H
    Li, H
    Soriano, P
    Betscholtz, C
    Heldin, CH
    Alitalo, K
    Östman, A
    Eriksson, U
    [J]. NATURE CELL BIOLOGY, 2000, 2 (05) : 302 - 309
  • [24] Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease
    MacDonald, TJ
    Brown, KM
    LaFleur, B
    Peterson, K
    Lawlor, C
    Chen, YD
    Packer, RJ
    Cogen, P
    Stephan, DA
    [J]. NATURE GENETICS, 2001, 29 (02) : 143 - 152
  • [25] McGary EC, 2002, CLIN CANCER RES, V8, P3584
  • [26] Identification of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 as a negative regulator of thioredoxin function and expression
    Nishiyama, A
    Matsui, M
    Iwata, S
    Hirota, K
    Masutani, H
    Nakamura, H
    Takagi, Y
    Sono, H
    Gon, Y
    Yodoi, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (31) : 21645 - 21650
  • [27] The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation
    Nomiyama, Takashi
    Nakamachi, Takafumi
    Gizard, Florence
    Heywood, Elizabeth B.
    Jones, Karrie L.
    Ohkura, Naganari
    Kawamori, Ryuzo
    Conneely, Orla M.
    Bruemmer, Dennis
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (44) : 33467 - 33476
  • [28] Downregulation of metastasis suppressor genes in malignant pheochromocytoma
    Ohta, S
    Lai, EW
    Pang, ALY
    Brouwers, FM
    Chan, WY
    Eisenhofer, G
    de Krijger, R
    Ksinantova, L
    Breza, J
    Blazicek, P
    Kvetnansky, R
    Wesley, RA
    Pacak, K
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (01) : 139 - 143
  • [29] Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
    Rikova, Klarisa
    Guo, Ailan
    Zeng, Qingfu
    Possemato, Anthony
    Yu, Jian
    Haack, Herbert
    Nardone, Julie
    Lee, Kimberly
    Reeves, Cynthia
    Li, Yu
    Hu, Yerong
    Tan, Zhiping
    Stokes, Matthew
    Sullivan, Laura
    Mitchell, Jeffrey
    Wetzel, Randy
    MacNeill, Joan
    Ren, Jian Min
    Yuan, Jin
    Bakalarski, Corey E.
    Villen, Judit
    Kornhauser, Jon M.
    Smith, Bradley
    Li, Daiqiang
    Zhou, Xinmin
    Gygi, Steven P.
    Gu, Ting-Lei
    Polakiewicz, Roberto D.
    Rush, John
    Comb, Michael J.
    [J]. CELL, 2007, 131 (06) : 1190 - 1203
  • [30] PLATELET-DEPENDENT SERUM FACTOR THAT STIMULATES PROLIFERATION OF ARTERIAL SMOOTH-MUSCLE CELLS INVITRO
    ROSS, R
    GLOMSET, J
    KARIYA, B
    HARKER, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (04) : 1207 - 1210